◆ NeutralNVS
All You Need to Know About Novartis (NVS) Rating Upgrade to Buy
Zacks Investment Research·
Novartis (NVS) has been upgraded to Zacks Rank #2 (Buy) due to upward trends in earnings estimates. The company is expected to earn $9.02 per share for fiscal year 2026, with analysts raising consensus estimates by 2% over the past three months. The upgrade positions Novartis in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation.
Read Full Article at Zacks Investment Research →